亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate

医学 放射性核素治疗 不良事件通用术语标准 累积发病率 细胞减少 内科学 白细胞减少症 累积剂量 不利影响 队列 神经内分泌肿瘤 毒性 核医学 胃肠病学 外科 骨髓
作者
Amir Sabet,Khaled Ezziddin,Ulrich‐Frank Pape,Hojjat Ahmadzadehfar,Karin Mayer,Thorsten Pöppel,Stefan Guhlke,Hans‐Jürgen Biersack,Samer Ezziddin
出处
期刊:The Journal of Nuclear Medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:54 (11): 1857-1861 被引量:146
标识
DOI:10.2967/jnumed.112.119347
摘要

Myelosuppression may be the dose-limiting toxicity in peptide receptor radionuclide therapy (PRRT). The aim of this study was to investigate the incidence, severity, and reversibility of long-term hematotoxicity in a large cohort of patient undergoing PRRT with (177)Lu-octreotate for metastatic neuroendocrine tumors. The impact of potential risk factors, including initial cytopenia, advanced bone metastatic disease, previous chemotherapy, and cumulative administered activity, and the protective effects of splenectomy were of particular interest.A total of 632 PRRT courses were performed in 203 patients with metastatic neuroendocrine tumors. A mean activity of 7.9 GBq of (177)Lu-octreotate was administered per treatment cycle, with a goal of 4 courses at standard intervals of 3 mo. Hematologic parameters were determined before each treatment course, at 2- to 4-wk intervals between the courses, 8-12 wk after the last course of PRRT, and at 3-month intervals for further follow-up. Toxicity was recorded with Common Terminology Criteria for Adverse Events (version 3.0).Myelodysplastic syndrome as a delayed adverse event was documented in 3 patients (1.4%). Relevant but reversible hematotoxicity (grade 3 or 4) occurred in 23 patients (11.3%) and 29 administrations (4.6%), with leukopenia in 2.7% and thrombocytopenia in 1.7%. The mean time to blood count recovery was 12 mo after the termination of PRRT (range, 3-22 mo). The only preexisting factor that contributed to hematotoxicity was initial cytopenia (P < 0.001). A high level of cumulative administered activity (>29.6 GBq) was associated with relevant leukopenia (P < 0.001). None of the patients with a history of splenectomy developed grade 3 or 4 hematotoxicity, and splenectomy was inversely associated with the incidence and degree of leukopenia (P = 0.02) and thrombocytopenia (P = 0.03).PRRT-induced myelosuppression is almost invariably reversible and rarely requires clinical measures. Administered activity and initial cytopenia are the only factors contributing to myelosuppression, whereas splenectomy may exert a protective effect.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界的应助被撩寮采纳,获得10
1秒前
康子浩发布了新的文献求助10
4秒前
多情嫣然完成签到,获得积分10
8秒前
9秒前
ZaZa完成签到,获得积分10
9秒前
12秒前
summerer发布了新的文献求助10
18秒前
Lucas的应助被科研通管家采纳,获得10
19秒前
852的应助被科研通管家采纳,获得10
20秒前
共享精神的应助被科研通管家采纳,获得10
20秒前
殷宵箫发布了新的文献求助10
20秒前
英姑的应助被科研通管家采纳,获得10
20秒前
含蓄的芝麻完成签到,获得积分10
22秒前
ADAB0002完成签到,获得积分10
23秒前
果冻完成签到 ,获得积分10
24秒前
24秒前
vfdhjng完成签到,获得积分20
26秒前
26秒前
可爱的函函的应助被lx采纳,获得10
28秒前
29秒前
华仔的应助被怡宝采纳,获得10
30秒前
summerer发布了新的文献求助20
31秒前
32秒前
嘻嘻哈哈的应助被Gloria采纳,获得10
32秒前
费洛蒙漩涡完成签到,获得积分10
33秒前
孤独孤风完成签到,获得积分10
33秒前
苹果颖完成签到,获得积分10
34秒前
lx完成签到,获得积分10
35秒前
36秒前
36秒前
科研通AI6.4的应助被殷宵箫采纳,获得10
36秒前
37秒前
鱼鱼鱼完成签到,获得积分10
39秒前
lx发布了新的文献求助10
41秒前
41秒前
顺心尔冬完成签到,获得积分10
41秒前
42秒前
康子浩发布了新的文献求助10
42秒前
cong发布了新的文献求助10
44秒前
科研通AI6.2的应助被追寻芷采纳,获得10
46秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165846
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749858
捐赠科研通 7756681
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553354
邀请新用户注册赠送积分活动 2473622